Literature DB >> 6805715

Prospective double-blind comparison of buprenorphine and pethidine in ureteric colic.

I G Finlay, R Scott, C S McArdle.   

Abstract

In a double-blind prospective trial 26 consecutive patients with proved ureteric colic were allocated at random to receive 100 mg pethidine or 0.3 mg buprenorphine by intramuscular injection. Pain relief was assessed by standard linear analogue and ordered categories scales. The mean pain relief on the linear analogue scale was 3.80 +/- SEM 0.64 in patients receiving pethidine and 6.86 +/- 0.40 in those receiving buprenorphine (p less than 0.001). The corresponding values for mean pain relief in the ordered categories scale was 1.78 +/- 0.26 v 2.76 +/- 0.20 (p less than 0.01). These observations suggest that buprenorphine is superior to pethidine as analgesia in ureteric colic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805715      PMCID: PMC1498725          DOI: 10.1136/bmj.284.6332.1830

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  7 in total

1.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

2.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Ring C-bridged derivatives of thebaine and oripavine.

Authors:  J W Lewis
Journal:  Adv Biochem Psychopharmacol       Date:  1973

4.  The frequency of urolithiasis in hospital discharge diagnoses in the United States.

Authors:  R Sierakowski; B Finlayson; R R Landes; C D Finlayson; N Sierakowski
Journal:  Invest Urol       Date:  1978-05

5.  Renal colic.

Authors:  A Walsh
Journal:  Br J Hosp Med       Date:  1978-03

6.  The prevalence of calcified upper urinary tract stone disease in a random population--Cumbernauld Health Survey.

Authors:  R Scott; R Freeland; W Mowat; M Gardiner; V Hawthorne; R M Marshall; J G Ives
Journal:  Br J Urol       Date:  1977

7.  Buprenorphine: a new potent long-acting synthetic analgesic. Comparison with morphine.

Authors:  J W Downing; W P Leary; E S White
Journal:  Br J Anaesth       Date:  1977-03       Impact factor: 9.166

  7 in total
  9 in total

1.  [Not Available].

Authors:  P Löhmer; W Tolksdorf
Journal:  Schmerz       Date:  1989-03       Impact factor: 1.107

2.  Standards for the use of ordinal scales in clinical trials.

Authors:  C R MacKenzie; M E Charlson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

3.  Analgesia in acute pancreatitis: comparison of buprenorphine and pethidine.

Authors:  S L Blamey; I G Finlay; D C Carter; C W Imrie
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

Review 4.  Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic.

Authors:  A Holdgate; T Pollock
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 5.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

6.  [Pain therapy in acute renal colic.].

Authors:  C Tschuschke; S C Müller; L Hertle
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

7.  Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial.

Authors:  Pooya Payandemehr; Mohammad Jalili; Babak Mostafazadeh Davani; Ahmad Reza Dehpour
Journal:  Int J Emerg Med       Date:  2014-01-03

8.  Post-operative Analgesia in Opioid Dependent Patients: Comparison of Intravenous Morphine and Sublingual Buprenorphine.

Authors:  Shaabanali Alizadeh; Ghafar Ali Mahmoudi; Hassan Solhi; Bahman Sadeghi-Sedeh; Reza Behzadi; Amir Mohammad Kazemifar
Journal:  Addict Health       Date:  2015 Winter-Spring

9.  Opium dependency in recurrent painful renal lithiasis colic.

Authors:  Ali Asghar Ketabchi; Mohammad Reza Ebad-Zadeh; Saeedeh Parvaresh; Golam Reza Moshtaghi-Kashanian
Journal:  Addict Health       Date:  2012 Winter-Spring
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.